# MyOrbitHealth vs. Fuse Health

Source: https://myorbithealth.com/compare/myorbit-vs-fuse-health · Details as of September 2026

MyOrbitHealth and Fuse Health both power branded telehealth businesses, but with different scopes. As of September 2026, Fuse positions itself around the peptide vertical — a 'Shopify for peptides' — with tiered subscription pricing. MyOrbitHealth is multi-vertical infrastructure: peptides plus GLP-1 weight loss, TRT and men's health, women's health, HRT, and more on one stack, with a published 50-state provider network and a REST API. If peptides are your only category forever, both belong on your shortlist; if you plan to expand, the infrastructure decision looks different. Details reflect public positioning as of September 2026 and can change.

## Side by side

| Dimension | MyOrbitHealth | Fuse Health |
| --- | --- | --- |
| Positioning | Multi-vertical white-label telehealth infrastructure (platform + API) | Peptide-focused white-label platform ('Shopify for peptides') |
| Verticals | GLP-1, HRT/TRT, peptides, women's health, sexual wellness, hair & skin, mental health, primary care, sleep, longevity, med-spa programs | Peptides as the core focus (as of September 2026) |
| Provider network | 2,400+ board-certified providers, 38+ specialties, all 50 states, avg response under 6 min (business hours) | Provider access appropriate to its peptide programs; network size not published |
| Developer / API | REST API + webhooks + React SDK, plus fully hosted white-label clinic | Platform-led; not positioned around a developer product |
| E-prescribing & pharmacy | EPCS-ready OrbitRx via Surescripts to a LegitScript-certified pharmacy network (compounding + retail) | Compounding fulfillment aligned to peptide programs |
| Pricing transparency | Transparent fee model (flat platform fee, 0% medication markup, no revenue share, brand is merchant of record); quotes are scoped | Tiered subscription pricing (per its published materials as of September 2026) |
| Expansion path | Add verticals on the same stack — no re-platforming, no patient migration | Strong inside peptides; expansion beyond the niche depends on its roadmap |
| Best for | Founders planning a multi-vertical brand, or peptide brands that expect to expand | Brands committed to peptides as the sole category |

## Where each fits

- MyOrbitHealth fits founders who want peptides today and the option of GLP-1, TRT, women's health, or other verticals tomorrow without switching infrastructure partners — plus product teams who want telehealth behind a REST API and React SDK.
- Fuse Health fits operators all-in on the peptide category who want a platform purpose-built around it. Full head-to-head: /blog/myorbit-vs-fuse-health.

## FAQ

### Is Fuse Health peptides-only?
As of September 2026, Fuse positions itself around the peptide vertical — often described as a 'Shopify for peptides.' Confirm its current category roadmap directly with Fuse.

### Does MyOrbitHealth support peptides too?
Yes — peptides are one of 11 live verticals, with 503A/503B compounding fulfillment through a LegitScript-certified pharmacy network.

### Why does multi-vertical infrastructure matter for a peptide brand?
Switching platforms mid-growth means migrating patients, re-papering legal structures, and re-earning ad-platform trust. Starting on multi-vertical infrastructure lets a peptide brand add GLP-1, TRT, or women's health later without that cost.

### Which should I choose?
If peptides will remain your only category, evaluate both — Fuse's focus is real. If you expect to expand within two years, MyOrbitHealth's vertical breadth, published provider network, and API are the differentiators. Confirm current details with each vendor.

Related: best white label telehealth platforms — https://myorbithealth.com/blog/best-white-label-telehealth-platforms · Book a call: https://myorbithealth.com/book